Because conventional formulations are limited by poor bioavailability, gastrointestinal intolerance, and suboptimal tissue targeting, innovative drug delivery systems, such as nanoparticles, pH-responsive hydrogels, and microneedles, are being developed to enhance therapeutic efficacy, reduce adverse effects, and improve patient adherence (Sulong et al., 2025)
Lipotropic injections: These are nutrient-based blends (often B12 + MIC) used as an adjunct
Core 157 Daily baseline 2-in-1 Pentadeca Arginate + PEA daily 5001000 mcg Tissue repair studies (preclinical) Stackable Start here Best overall Stack 157 Multi-compound 3-in-1 Pentadeca Arginate + 4 Frag + PEA 3000 mcg formula Two-stage delivery Joint gut tissue together You are here Gut 157 Gut-focused New Mucoadhesive matrix Supports gut barrier integrity Supports gut mucosal research (preclinical) Stackable Gut first Tested
These include Crohns disease, celiac disease, or atrophic gastritis (chronic inflammation of the stomach lining)